There has been an increase in the incidences of inflammatory bowel diseases which are very chronic in nature and at the same time are so infectious that they are likely to reduce the working efficiency of the person. These are biomarkers for the development of the disease and hence, help the patient to be wary of it and hence, look for the desired and the right clinical treatment. Therefore, various studies have been conducted so far using the interleukin 10 gene-deficient murine model which will be helping people to predict and adapt to early life dysbiosis instead of being dependent on antibiotics. The results have showcased that as compared to controls, the offspring acquiring maternal CPZ is nothing but the induced dysbiosis itself. Therefore, an attempt is made to ensure that the intestinal microbial membership in both bacteriome and mycobiome is linked with the alterations in specific functional systems. Hence, an attempt is made to cure them in the best possible manner without reporting much harm.
Ref art: https://www.annalsthoracicsurgery.org/article/S0003-4975(02)04323-0/fulltext